Synergistic antitumor effects of carboplatin and interferons on hepatic metastases of colon carcinoma 26 and M5076 reticulum cell sarcoma
- PMID: 8370655
- PMCID: PMC5919198
- DOI: 10.1111/j.1349-7006.1993.tb02046.x
Synergistic antitumor effects of carboplatin and interferons on hepatic metastases of colon carcinoma 26 and M5076 reticulum cell sarcoma
Abstract
The effects of combination therapy including various antitumor agents and interferon on mice bearing hepatic metastases of colon carcinoma 26 were determined. Combined treatment with interferon-alpha A/D and carboplatin (CBDCA) was associated with a considerably more pronounced antitumor effect than was treatment with either drug alone. Murine interferon-beta and -gamma each also potentiated the antitumor activity of CBDCA. Combination therapy with interferon-alpha A/D and CBDCA also resulted in marked inhibition of hepatic metastasis of M5076 reticulum cell sarcoma. However, interferon-beta did not potentiate the antitumor activity of CBDCA against either subcutaneously implanted colon carcinoma 26 or pulmonary metastases of this tumor. Thus, in our model the combined administration of interferon and CBDCA was associated with a synergistic antitumor effect on hepatic metastases alone.
Similar articles
-
Tranilast inhibits the growth and metastasis of mammary carcinoma.Anticancer Drugs. 2009 Jun;20(5):334-45. doi: 10.1097/CAD.0b013e328327994e. Anticancer Drugs. 2009. PMID: 19322072
-
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.Cancer Res. 1994 Oct 15;54(20):5380-6. Cancer Res. 1994. PMID: 7923169
-
Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.Anticancer Res. 2000 Nov-Dec;20(6B):4473-6. Anticancer Res. 2000. PMID: 11205290
-
Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.Cancer Chemother Pharmacol. 1994;35(1):10-6. doi: 10.1007/BF00686278. Cancer Chemother Pharmacol. 1994. PMID: 7527303
-
Antitumor effects of interferon.Acta Oncol. 1989;28(3):347-53. doi: 10.3109/02841868909111205. Acta Oncol. 1989. PMID: 2472822 Review.
References
-
- ) Wadler , S. and Wiernik , P. H.Clinical update on the role of fluorouracil and recombinant interferon alfa‐2a in the treatment of colorectal carcinoma . Semin. Oncol. , 17 , 16 – 21 ( 1990. ). - PubMed
-
- ) Elias , L. and Sandoval , J. M.Interferon effects upon fluorouracil metabolism by HL‐60 cells . Biochem. Biophys. Res. Commun. , 163 , 867 – 874 ( 1989. ). - PubMed
-
- ) Knight , E. , Jr. and Korant , B. D.A cell surface alteration in mouse L cells induced by interferon . Biochem. Biophys. Res. Commun. , 74 , 707 – 713 ( 1977. ). - PubMed
-
- ) Brunda , M. J. , Rosenbaum , D , and Stern , L.Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases . Int. J. Cancer , 34 , 421 – 426 ( 1984. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical